SIM
DOVA

Spark Investment Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Spark Investment Management’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-80,500
Closed -$715K – 804
2019
Q1 		$715K Buy
80,500
+19,400
+32% +$157K 0.03% 374
2018
Q4 		$463K Buy
+61,100
New +$984K 0.03% 411

Other funds holding DOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spark Investment Management's DOVA Position: Q2 2019 in Review

Spark Investment Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q2 2019, closing a stake of 80,500 shares — an estimated $715K sold.

Spark Investment Management first reported a position in DOVA in Q4 2018 and held it in 2 quarters. The position peaked at $715K in Q1 2019. 66 funds tracked by Wall St. Rank hold DOVA as of Q2 2019.

  • Spark Investment Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Spark Investment Management sold 80,500 Dova Pharmaceuticals, Inc. Common Stock shares in Q2 2019, an estimated $715K.
  • Spark Investment Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Spark Investment Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $715K in Q1 2019.
  • 66 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q2 2019.

Based on Spark Investment Management's 13F filing for Q2 2019, filed 12 Aug 2019.